A bill to promote competition in the market for drugs and biological products by facilitating the timely entry of lower-cost generic and biosimilar versions of those drugs and biological products.
The bill’s titles are written by its sponsor.
Sponsor and status
Sponsor. Senior Senator for Vermont. Democrat.
Last Updated: Jun 21, 2018
Length: 42 pages
115th Congress (2017–2019)
This bill was introduced on June 14, 2018, in a previous session of Congress, but it did not receive a vote.
What legislators are saying
“Grassley: Legislation Will Improve Competition for Rx Drugs & Save Taxpayer Dollars”
— Sen. Charles “Chuck” Grassley [R-IA] (Co-sponsor) on Jun 14, 2018
“Daines Sponsors Bill to Increase Access to Lower-Cost Generic Drugs”
— Sen. Steve Daines [R-MT] (Co-sponsor) on Mar 12, 2018
“Grassley Statement Ahead of Committee Votes on Circuit, District Court Nominees and Opioid Bill”
— Sen. Charles “Chuck” Grassley [R-IA] (Co-sponsor) on Jun 7, 2018
What stakeholders are saying
Apr 27, 2017
Bills and resolutions are referred to committees which debate the bill before possibly sending it on to the whole chamber.
Jun 7, 2018
Considered by Senate Committee on the Judiciary
A committee held a hearing or business meeting about the bill.
Jun 14, 2018
A committee has voted to issue a report to the full chamber recommending that the bill be considered further. Only about 1 in 4 bills are reported out of committee.
S. 974 (115th) was a bill in the United States Congress.
A bill must be passed by both the House and Senate in identical form and then be signed by the President to become law.
Bills numbers restart every two years. That means there are other bills with the number S. 974. This is the one from the 115th Congress.
This bill was introduced in the 115th Congress, which met from Jan 3, 2017 to Jan 3, 2019. Legislation not passed by the end of a Congress is cleared from the books.
How to cite this information.
We recommend the following MLA-formatted citation when using the information you see here in academic work:
GovTrack.us. (2021). S. 974 — 115th Congress: Creating and Restoring Equal Access to Equivalent Samples Act of 2018. Retrieved from https://www.govtrack.us/congress/bills/115/s974
“S. 974 — 115th Congress: Creating and Restoring Equal Access to Equivalent Samples Act of 2018.” www.GovTrack.us. 2017. March 6, 2021 <https://www.govtrack.us/congress/bills/115/s974>
Creating and Restoring Equal Access to Equivalent Samples Act of 2018, S. 974, 115th Cong. (2017).
|title=S. 974 (115th)
|accessdate=March 6, 2021
|author=115th Congress (2017)
|date=April 27, 2017
|quote=Creating and Restoring Equal Access to Equivalent Samples Act of 2018
Where is this information from?
GovTrack automatically collects legislative information from a variety of governmental and non-governmental sources. This page is sourced primarily from Congress.gov, the official portal of the United States Congress. Congress.gov is generally updated one day after events occur, and so legislative activity shown here may be one day behind. Data via the congress project.